Industry Insights

• 
  Leading the Development of Bispecific ADCs, Multiple Chinese New Drugs Go Global Yi
  December 20, 2024
  On November 18, it was announced that VelaVigo has entered into a global strategic cooperation agreement with Avenzo Therapeutics.
• 
  New Pathways for Innovation and Transformation of Local Pharmaceutical Companies Xiaobin
  December 20, 2024
  INNOVATION announced it will acquire 100% equity in CSPC Baike for up to RMB 7.6 billion, 10% in cash and 90% in shares.
• 
  Established Pharmaceutical Company Makes a High-profile Entrance with "Unlimited" R&D Investment, Signaling an Imminent Explosion in This Emerging Field xiaobin
  December 20, 2024
  Recently, Northeast Pharm announced its plan to acquire a 70% stock equity in Dingcheng Taiyuan for a total cash consideration of approximately RMB 187 million, thereby obtaining controlling stake in the company.

• 
  Future Directions and Challenges to Desmoid Tumors and Nirogacestat David Orchard-Webb
  January 07, 2025
  Desmoid tumors, also known as aggressive fibromatosis, are uncommon non-metastatic soft tissue tumors distinguished by the proliferation of fibroblasts and myofibroblasts.

• 
  AI in Pharmacovigilance: Predicting & Preventing Drug Risks Nurah Ekhlaque
  November 19, 2024
• 
  Thrombolytic Science Announces FDA’s IND Clearance of Mutant Prourokinase for the Treatment of Thrombotic Diseases PharmaSources
  October 15, 2024
• 
  Eleva Appoints Dr. Elisabeth Lackner to its Supervisory Board Adding Broad Biopharmaceutical Industry Expertise to the Organization PharmaSources
  October 15, 2024
  Eleva, a pioneer in unlocking difficult-to-produce biologics based on a breakthrough manufacturing platform, announced today the appointment of Dr. Elisabeth Lackner to its Supervisory Board.

• 
  Research and Application of Artemisia Argyi Xiaonisha
  August 12, 2024
  Mugwort, also known as fragrant mugwort or Artemisia argyi, is a herbaceous plant belonging to the Compositae family.
• 
  Research Progress on the Application of Biologics in Pediatric Asthma Xiaomichong
  July 19, 2024
• 
  Research Progress on the Pharmacological Effects and New Drug Forms of Artemisinin and Its Derivatives Xiaomichong
  July 19, 2024

• 
  20 Years of Growth and Innovation in China, Fette Compacting Launches F30p Tablet Press PharmaSources
  December 13, 2024
  Interview Dr. Andreas Risch——Managing Director of Fette Compacting (China) Co., Ltd.